Acne. L70.0
Conditions
Interventions
Intervention 1: Intervention group: The study population is patients with moderate to severe active facial acne referring to Hazrat Rasool Akram Hospital. Affected patients were examined by a dermatol
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 50 Years
Inclusion criteria
Inclusion criteria: Patient between 15 and 50 years old Patients with a confirmed diagnosis of facial active acne During the last 3 months, the patient has not received any treatment for the disease. Lack of underlying disease The patient's cooperation in carrying out therapeutic interventions and referring for all therapeutic sessions
Exclusion criteria
Exclusion criteria: The patient has been treated for acne in the last three months The presence of a serious underlying disease in the person
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effectiveness of laser treatment on acne. Timepoint: Determining the severity of acne at the beginning of treatment and 4 weeks after the end of treatment. Method of measurement: Clinical evaluation by photographing with Canon EOS 750D digital photography camera in room light and also counting the number of active lesions 2. Determination of acne severity using Leeds revised acne grading system which is based on the lesions in the photo and comparing with existing criteria from 1 to 12 The severity of acne is scored. 3. Examining the severity of acne using the global acne grading system) which is based on the location of acne lesions on the face and also based on the type of lesions from comedone type to papule, pustule and nodulocystic acne with a score from 1 to 44 It is considered that grade 1 to 18 is mild, 19 to 30 is moderate, 31 to 38 is severe, and a grade equal to or greater than 39 is considered very severe.4. The degree of satisfaction of the doctor and the patient with the treatment based on the physician/patient global assessment score: (completely satisfied, satisfied, neither satisfied nor dissatisfied, dissatisfied and completely dissatisfied)The photos are reviewed and scored by a dermatologist who is blind to the study, and at the end, the study data is analyzed by a blind statistician.;Safety of treatment. Timepoint: Examination of treatment side effects before and after each session and 4 weeks after the end of treatment. Method of measurement: Using doctor and patient questionnaires (including pain, swelling, erythema and PIH).;Tolerability of the treatment. Timepoint: Checkiing the tolerability of the treatment before and after each session and 4 weeks after the end of the treatment. Method of measurement: Using a questionnaire (yes, no). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAzadeh goodarzi
Iran University of Medical Sciences
Outcome results
None listed